Pharma Fast 50

We are extremely excited to announce that we have been named in this year’s Pharma Fast 50, an annual ranking of the UK’s fastest-growing companies within the pharmaceutical industry.

The annual ranking, which is presented by The PharmaTimes, was first published last year as the Catalyst Pharma Fast 50 and has since merged with Alantra, the global investment bank. Businesses are selected for their rapid revenue growth over the past two years and are very often found to be working closely with big pharma.

The analysis divides companies into four distinct sub-sectors – outsourcing; development, wholesale and supply; consulting; and pharmacy chains. Random42 was ranked top within the consulting sub-sector this year, with annualised revenue growth of 34 percent over the past two years, receiving an overall ranking, across all four sub-sectors, of thirteen. Pharma Fast 50 helps notify the pharma industry of the companies to watch out for, and the supplementary analysis provides an in-depth look at the most important trends affecting the industry right now.

For more on the Pharma Fast 50 read the full article.

 

Ben Ramsbottom, Random42 CEO and Medical Director commented on this fantastic achievement:

 It is great to be recognised for the hard work that has gone into growing Random42 over the last couple of years. This has involved broadening our offering into areas such as virtual reality, augmented reality, interactive installations, in addition to furthering our scientific and creative expertise in developing immersive animations. This has clearly been done with the support of a highly skilled team, with the intent of constantly improving the various products that we offer. We look forward to continuing this growth whilst maintaining the high end products that support this expansion.